NASDAQ:OVID - Ovid Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.78 -0.09 (-4.81 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$1.87
Today's Range$1.77 - $1.88
52-Week Range$1.72 - $11.45
Volume126,554 shs
Average Volume201,767 shs
Market Capitalization$68.79 million
P/E Ratio-0.84
Dividend YieldN/A

Analyst Ratings

Ovid Therapeutics (NASDAQ:OVID) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Ovid Therapeutics in the last 12 months. Their average twelve-month price target is $15.50, suggesting that the stock has a possible upside of 770.79%. The high price target for OVID is $27.00 and the low price target for OVID is $10.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $15.50$19.00$19.00$23.50
Price Target Upside: 770.79% upside533.33% upside533.33% upside281.49% upside

Ovid Therapeutics (NASDAQ:OVID) Consensus Price Target History

Price Target History for Ovid Therapeutics (NASDAQ:OVID)

Ovid Therapeutics (NASDAQ:OVID) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/10/2019Piper Jaffray CompaniesLower Price TargetOverweight$14.00LowView Rating Details
3/8/2019LADENBURG THALM/SH SHSet Price TargetBuy$27.00LowView Rating Details
3/8/2019JMP SecuritiesLower Price TargetOutperform$26.00 ➝ $11.00MediumView Rating Details
12/17/2018Cantor FitzgeraldSet Price TargetBuy$10.00MediumView Rating Details
4/1/2018CowenReiterated RatingBuyHighView Rating Details
5/30/2017CitigroupInitiated CoverageBuy ➝ Buy$21.00HighView Rating Details
5/30/2017William BlairInitiated CoverageOutperform ➝ OutperformHighView Rating Details
(Data available from 3/26/2017 forward)
This page was last updated on 3/26/2019 by Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel